{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:10:43Z","timestamp":1789020643485,"version":"build-2803163510"},"reference-count":53,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:00:00Z","timestamp":1584748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomaterials"],"abstract":"<jats:p>The active targeting to alveolar macrophages (AM) is an attractive strategy to improve the therapeutic efficacy of \u2018old\u2019 drugs currently used in clinical practice for the treatment of pulmonary tuberculosis. Previous studies highlighted the ability of respirable solid lipid nanoparticle assemblies (SLNas), loaded with rifampicin (RIF) and functionalized with a novel synthesized mannose-based surfactant (MS), both alone and in a blend with sodium taurocholate, to efficiently target the AM via mannose receptor-mediated mechanism. Here, we present the in vivo biodistribution of these mannosylated SLNas, in comparison with the behavior of both non-functionalized SLNas and bare RIF. SLNas biodistribution was assessed, after intratracheal instillation in mice, by whole-body real-time fluorescence imaging in living animals and RIF quantification in excised organs and plasma. Additionally, SLNas cell uptake was determined by using fluorescence microscopy on AM from bronchoalveolar lavage fluid and alveolar epithelium from lung dissections. Finally, histopathological evaluation was performed on lungs 24 h after administration. SLNas functionalized with MS alone generated the highest retention in lungs associated with a poor spreading in extra-pulmonary regions. This effect could be probably due to a greater AM phagocytosis with respect to SLNas devoid of mannose on their surface. The results obtained pointed out the unique ability of the nanoparticle surface decoration to provide a potential more efficient treatment restricted to the lungs where the primary tuberculosis infection is located.<\/jats:p>","DOI":"10.3390\/nano10030568","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T04:03:01Z","timestamp":1584936181000},"page":"568","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?"],"prefix":"10.3390","volume":"10","author":[{"given":"Eleonora","family":"Truzzi","sequence":"first","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2656-7609","authenticated-orcid":false,"given":"Thais Leite","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutical Technology, Federal University of Goi\u00e1s, Goi\u00e2nia, Goi\u00e1s 74605-170, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-5794","authenticated-orcid":false,"given":"Valentina","family":"Iannuccelli","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Costantino","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-5803","authenticated-orcid":false,"given":"Eliana Martins","family":"Lima","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutical Technology, Federal University of Goi\u00e1s, Goi\u00e2nia, Goi\u00e1s 74605-170, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-1676","authenticated-orcid":false,"given":"Eliana","family":"Leo","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1642-832X","authenticated-orcid":false,"given":"Cristina","family":"Siligardi","sequence":"additional","affiliation":[{"name":"Department of Engineering \u201cEnzo Ferrari\u201d, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-2661","authenticated-orcid":false,"given":"Magdalena Lassinantti","family":"Gualtieri","sequence":"additional","affiliation":[{"name":"Department of Engineering \u201cEnzo Ferrari\u201d, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0048-2612","authenticated-orcid":false,"given":"Eleonora","family":"Maretti","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,21]]},"reference":[{"key":"ref_1","unstructured":"WHO (2019). Global Tuberculosis Report, WHO."},{"key":"ref_2","first-page":"429","article-title":"Antibiotic uptake by alveolar macrophages","volume":"95","author":"Johnson","year":"1980","journal-title":"J. Lab. Clin. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2009.11.020","article-title":"Delivery of rifampicin\u2013PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis","volume":"142","author":"Hirota","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425247.2015.1039509","article-title":"Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages","volume":"12","author":"Lee","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hickey, A.J., and Mansour, H.M. (2019). Inhalation Aerosols|Physical and Biological Basis for Therapy, CRC Press. [3rd ed.].","DOI":"10.1201\/9781315159768"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13346-018-00607-w","article-title":"Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy","volume":"9","author":"Maretti","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijpharm.2014.12.009","article-title":"Pulmonary drug delivery systems for tuberculosis treatment","volume":"478","author":"Pham","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_8","first-page":"7","article-title":"Pulmonary drug delivery system: Review","volume":"5","author":"Chaturvedi","year":"2013","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2147\/DDDT.S104395","article-title":"Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis","volume":"10","author":"Pinheiro","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0022-3859.41823","article-title":"Low-dose inhaled versus standard dose oral form of anti-tubercular drugs: Concentrations in bronchial epithelial lining fluid, alveolar macrophage and serum","volume":"54","author":"Katiyar","year":"2008","journal-title":"J. Postgrad. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.3390\/ijms15045852","article-title":"Nanoparticle-mediated pulmonary drug delivery: A review","volume":"15","author":"Paranjpe","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.chemphyslip.2014.03.006","article-title":"Drug targeting using solid lipid nanoparticles","volume":"181","author":"Rostami","year":"2014","journal-title":"Chem. Phys. Lipids"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jac\/dkl533","article-title":"Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra","volume":"59","author":"Sharma","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_14","first-page":"e102","article-title":"Inhaled Micro- or Nanoparticles: Which are the Best for Intramacrophagic Antiinfectious Therapies?","volume":"1","author":"Iannuccelli","year":"2015","journal-title":"J. Infect. Dis. Diagn"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10717540801952530","article-title":"Lipid Microsphere Formulation Containing Rifampicin Targets Alveolar Macrophages","volume":"15","author":"Takenaga","year":"2008","journal-title":"Drug Delivery"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijpharm.2013.12.034","article-title":"Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis","volume":"462","author":"Maretti","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Maretti, E., Rustichelli, C., Lassinantti Gualtieri, M., Costantino, L., Siligardi, C., Miselli, P., Buttini, F., Montecchi, M., Leo, E., and Truzzi, E. (2019). The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11100508"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1128\/AAC.00153-08","article-title":"Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice","volume":"52","author":"Verma","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/jamp.2009.0797","article-title":"Update on macrophage clearance of inhaled micro- and nanoparticles","volume":"23","author":"Geiser","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1021\/nn505399e","article-title":"Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium","volume":"8","author":"Thorley","year":"2014","journal-title":"ACS Nano"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1021\/acsnano.6b08551","article-title":"Inhaled Nanoparticles Accumulate at Sites of Vascular Disease","volume":"11","author":"Miller","year":"2017","journal-title":"ACS Nano"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"El-Sherbiny, I.M., El-Baz, N.M., and Yacoub, M.H. (2015). Inhaled nano- and microparticles for drug delivery. Glob Cardiol Sci. Pract., 2015.","DOI":"10.5339\/gcsp.2015.2"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijpharm.2016.07.062","article-title":"Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment\u2014A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability","volume":"511","author":"Maretti","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated Biological Fluids with Possible Application in Dissolution Testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolut. Technol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejps.2018.08.010","article-title":"Design and validation of a simple device for insufflation of dry powders in a mice model","volume":"123","author":"Chaurasiya","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/17435390.2015.1054908","article-title":"Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles","volume":"10","author":"Hillaireau","year":"2016","journal-title":"Nanotoxicology"},{"key":"ref_27","first-page":"1","article-title":"Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics","volume":"1","author":"Azad","year":"2014","journal-title":"J. Cytol. Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12989-017-0200-x","article-title":"Early pulmonary response is critical for extra-pulmonary carbon nanoparticle mediated effects: Comparison of inhalation versus intra-arterial infusion exposures in mice","volume":"14","author":"Ganguly","year":"2017","journal-title":"Part. Fibre. Toxicol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijpharm.2013.11.042","article-title":"The impact of pulmonary diseases on the fate of inhaled medicines\u2014A review","volume":"461","author":"Wang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.2147\/IJN.S163925","article-title":"Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain","volume":"13","author":"Hakkimane","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1021\/acsami.6b16705","article-title":"Hydrophobic IR-780 Dye Encapsulated in cRGD-Conjugated Solid Lipid Nanoparticles for NIR Imaging-Guided Photothermal Therapy","volume":"9","author":"Kuang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12967-016-1115-2","article-title":"Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles","volume":"15","author":"Li","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/01902148.2019.1621408","article-title":"Inhaled salbutamol from aerolizer and diskus at different inhalation flows, inhalation volume and number of inhalations in both healthy subjects and COPD patients","volume":"45","author":"Boshra","year":"2019","journal-title":"Exp. Lung Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/01902148.2018.1489015","article-title":"Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers","volume":"44","author":"Boshra","year":"2018","journal-title":"Exp. Lung Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1208\/s12249-017-0841-y","article-title":"Study of the Emitted Dose After Two Separate Inhalations at Different Inhalation Flow Rates and Volumes and an Assessment of Aerodynamic Characteristics of Indacaterol Onbrez Breezhaler\u00ae 150 and 300 \u03bcg","volume":"19","author":"Abadelah","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1289\/ehp.9685","article-title":"Efficient elimination of inhaled nanoparticles from the alveolar region: Evidence for interstitial uptake and subsequent reentrainment onto airways epithelium","volume":"115","author":"Takenaka","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/jbio.201500271","article-title":"In vivo autofluorescence in the biological windows: The role of pigmentation","volume":"9","author":"Villa","year":"2016","journal-title":"J. Biophotonics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/08958378.2016.1189985","article-title":"Comparison of cell counting methods in rodent pulmonary toxicity studies: Automated and manual protocols and considerations for experimental design","volume":"28","author":"Antonini","year":"2016","journal-title":"Inhal. Toxicol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1152\/jappl.1988.64.5.1953","article-title":"Comparative physiology of rodent pulmonary macrophages: In vitro functional responses","volume":"64","author":"Warheit","year":"1988","journal-title":"J. Appl. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2249.1999.00762.x","article-title":"Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice","volume":"115","author":"Sapru","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/01902149209064338","article-title":"Alveolar and interstitial macrophage populations in the murine lung","volume":"18","author":"Crowell","year":"1992","journal-title":"Exp. Lung Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1183\/09031936.95.08101712","article-title":"Efficiency of airway macrophage recovery by bronchoalveolar lavage in hamsters: A stereological approach","volume":"8","author":"Geiser","year":"1995","journal-title":"Eur. Respir. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/1076327041348365","article-title":"Simple approach to micropattern cells on common culture substrates by tuning substrate wettability","volume":"10","author":"Tan","year":"2004","journal-title":"Tissue Eng."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ghadiri, M., Young, P.M., and Traini, D. (2019). Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030113"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/jamp.2017.1379","article-title":"Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis","volume":"30","author":"Rawal","year":"2017","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2010.05.021","article-title":"Involvement of mannose receptor in the preventive effects of mannose in lipopolysaccharide-induced acute lung injury","volume":"641","author":"Xu","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.4049\/jimmunol.171.9.4552","article-title":"Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program","volume":"171","author":"Chieppa","year":"2003","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1189\/jlb.1204699","article-title":"Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro","volume":"78","author":"Zhang","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e01539","DOI":"10.1016\/j.heliyon.2019.e01539","article-title":"Glucosamine\/L-lactide copolymers as potential carriers for the development of a sustained rifampicin release system using Mycobacterium smegmatis as a tuberculosis model","volume":"5","author":"Ragusa","year":"2019","journal-title":"Heliyon"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.05.269","article-title":"In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery","volume":"210","author":"Woods","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/AAC.00500-12","article-title":"Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs","volume":"56","author":"Dutta","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/314760","article-title":"Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis","volume":"179","author":"Nau","year":"1999","journal-title":"J. Infect. Dis."}],"container-title":["Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4991\/10\/3\/568\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:10:19Z","timestamp":1760173819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4991\/10\/3\/568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,21]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["nano10030568"],"URL":"https:\/\/doi.org\/10.3390\/nano10030568","relation":{},"ISSN":["2079-4991"],"issn-type":[{"value":"2079-4991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,21]]}}}